Impact économique des stratégies de prise en charge du diabète gestationnel

Diabetes and Metabolism

Volumn 23, Issue SUPPL. 5, 1997, Pages 40-47

  Chaix, C ^a   Durand Zaleski, I ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIBLIOGRAPHIC DATABASE; CESAREAN SECTION; COST; DIABETES MELLITUS; ECONOMICS; FEMALE; HUMAN; MACROSOMIA; MEDLINE; NEWBORN; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW;

CESAREAN SECTION; COSTS AND COST ANALYSIS; DATABASES, BIBLIOGRAPHIC; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; HUMANS; INFANT, NEWBORN; MEDLINE; PREGNANCY;

EID: 2542481152     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Engelgau MM, Herman WH, Smith PJ, German RR, Auber RE. The epidemiology of diabetes nad pregnancy in the US. 1988. Diabetes Care, 1995, 18, 1029-1033.
2. Koukkou E, Taub N, Jackson P, Metcalfe G, Cameron M, Lowy C. Difference in prevalence of gestational diabetes and perinatal outcome in an innercity multiethnic London population. Eur J Obstel Gynecol Reprod Biol, 1995, 59, 153-157.
3. Dornhorst A, Beard RW. Gestational diabetes : a challenge for the future. Diabetic medicine, 1993, 10, 897-905.
4. Fraser D, Weitzman S, Leiberman JR, Zmora E, Laron E, Karplus M. Gestational diabetes among Bedouind in southern Israel : comparison of prevalence and neonatal outcomes with the Jewish population. Acta Diabetologica, 1994, 31, 78-81.
5. Stephenson MJ. Screening for gestational diabetes mellitus : a critical review. Journal of family Practice, 1993, 37, 277-283.
6. Nahum GG, Huffaker BJ. Racial differences in oral glucose screening test results : establishing race-specific criteria for abnormality in pregnancy. J Obstet Gynecol, 1993, 81, 517-522.
7. Sacks DA. Fetal macrosomia and gestational diabetes : what's the problem ?. J Obstet Gynecol, 1993, 81, 775-781.
8. Task force on principles for economic analysis of health care technology. Economic analysis of health care technology, a report on principles. Ann Int Med, 1995. 122, 61-70.
9. Drummond M, Stoddart J, Torrance G. Economic evaluation of healthcare programmes. Oxford 1996, Oxford University Press.
10. Ryan E. To screen or not to screen ?. Can Med Assoc J, 1993, 148.
11. Coustan DR, Carpenter MW, O'Sullivan PS, Carr SR. Gestational diabetes : predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol, 1993, 168, 1139-1144.
12. Coustan DR. Methods of screening for and diagnosing of gestational diabetes. Clinics in Perinatology, 1993, 20, 593-602.
13. Weeks JW, Major CA, de Veciana M, Morgan MA. Gestational diabetes : does the presence of risk factors influence perinatal outcome ?. Am J Obstet Gynecol, 1994, 171, 1003-1007.
14. Griffiths RD, Rogers DV, Moses RG. Pateints' attitudes toward screening for gestational diabetes mellitus in the Illawarra area, Australia. Diabetes Care. 1993, 16, 506-508.
15. de Veciana M, Major MA, Asrat T, Toohey JS, Lien JM, Evans AT. Postprandialversus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. New England Journal of Medicine, 1995, 333, 1237-1241.
16. Smits MW, Paulk TH, Kee CC. Assessing the impact of an outpatient education programm for patients with gestational diabetes. Diabetes Educator, 1995, 21, 129-134.
17. Jackson P, Bash DM. Management of the uncomplicated pregnancy diabetic client in the ambulatory setting. Nurse Practioner, 1994, 19, 64-73.
18. Moses RG. The medical management of gestational diabetes in Australia within a solo private practice. Diabetic medicine, 1994, 11, 597-600.
19. Mazze RS. Treatment of glucose intolerance in Pregnancy : staged diabetes management. International Journal of Clinical Pharmacology, Therapy, Toxicology, 1993, 31, 497-505.
20. Huddleston JF, Cramer MK, Vroon DH. A rationale for omitting two-hour postprandial glucose determinations in gestational diabetes. Am J Obstet Gynecol, 1993, 762, 257-262.
21. Langer O., Rodriguez DA, Xcnakius EM, McFarland MB, Berkus MD, Arrendondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol, 1994, 170, 1036-1046.
22. Triomphe A, Flori YA, Lanoe JL. The costs of diabetes to society and the individual. In : Williams R, Papoz L, Fuller J. Diabetes in Europe, London 1993 John Libbey, 153-160.
23. Herman WH, Dasbach EJ, Songer TYJ, Thompson DE, Croford OB. Assessing the impact of intensive insulin therapy on the health care system. Diabetes Reviews, 1994, 2,384-388.
24. Elixhauser A, Weschler J, Kitzmiller J, Marks J. Bennert H, Coustan D, et al. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care, 1993, 16, 1146-1157.
25. Kjos SL, Henry OA, Montoro M, Buchanan TA, Mestman JH. Insulin-requiring daibetes in pregnancy : a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol, 1993, 169, 611-615.
26. Langer N, Langer O. Emotional adjustement to diagnosis and intensified treatment of gestational diabetes. J Obstet Gynecol, 1994, 84, 329-334.
27. Sjorgren B, Robeus N, Hansson U. Gestational diabetes : a case-control study of women's experience of pregnancy, health and the child. J of Psychosomatic Research, 1994. 38, 815-822.
28. Gregory KD, Kjos SL, Peters RK. Cost of non-insulin-dependant diabetes in womenwith a history of gestational diabetes : implication for prevention. J Obstet Gynecol, 1993, 81, 782-786.
29. The diabetes control and complications trial research group. Resource utilization and cost of care in the diabetes control and complications trial. Diabetes Care, 1995, 18, 1468-1478.
30. Magee MS, Walden CE, benedetti TJ, Knopp RH. Influence of diagnosis criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA, 1993, 269, 609-615.
31. Langer O, Langer N, Piper JM, Ellitt B, Anyaegbunam A. Cultural diversity as a factor in self-monitoring blood glucose in gestational diabetes. J Assoc for Academic Minority Physicians, 1995, 6, 73-77.